Simon Dumesnil - Sep 14, 2021 Form 3 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role
Director
Signature
/s/ Simon Dumesnil
Stock symbol
KTTA
Transactions as of
Sep 14, 2021
Transactions value $
$0
Form type
3
Date filed
9/14/2021, 09:53 PM
Next filing
Nov 17, 2022

No securities are beneficially owned.